Ironwood Pharmaceuticals, Inc.
IRWD
$4.31
$0.235.64%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 6.14% | 123.24% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.14% | 123.24% | |||
| Cost of Revenue | 2.19% | 0.35% | |||
| Gross Profit | 7.16% | 227.19% | |||
| SG&A Expenses | -5.98% | -37.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.70% | -17.06% | |||
| Operating Income | 9.34% | 975.20% | |||
| Income Before Tax | 13.13% | 14,223.52% | |||
| Income Tax Expenses | -8.03% | 793.41% | |||
| Earnings from Continuing Operations | 25.80% | 1,891.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 25.80% | 1,891.43% | |||
| EBIT | 9.34% | 975.20% | |||
| EBITDA | 9.30% | 912.71% | |||
| EPS Basic | 25.05% | 1,882.14% | |||
| Normalized Basic EPS | 12.53% | 31,037.50% | |||
| EPS Diluted | 29.17% | 1,095.85% | |||
| Normalized Diluted EPS | 12.86% | 30,425.00% | |||
| Average Basic Shares Outstanding | 0.58% | 0.62% | |||
| Average Diluted Shares Outstanding | 0.29% | 2.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||